These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat. Xing AP; Hu XY; Shi YW; Du YC Inhal Toxicol; 2012 Jul; 24(8):468-75. PubMed ID: 22746397 [TBL] [Abstract][Full Text] [Related]
44. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension. Tang H; Chen J; Fraidenburg DR; Song S; Sysol JR; Drennan AR; Offermanns S; Ye RD; Bonini MG; Minshall RD; Garcia JG; Machado RF; Makino A; Yuan JX Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L208-20. PubMed ID: 25416384 [TBL] [Abstract][Full Text] [Related]
45. Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension. Liu P; Yan S; Chen M; Chen A; Yao D; Xu X; Cai X; Wang L; Huang X Int J Mol Med; 2015 Apr; 35(4):901-8. PubMed ID: 25716558 [TBL] [Abstract][Full Text] [Related]
46. Expression and role of factor inhibiting hypoxia-inducible factor-1 in pulmonary arteries of rat with hypoxia-induced hypertension. Fu D; Dai A; Hu R; Chen Y; Zhu L Acta Biochim Biophys Sin (Shanghai); 2008 Oct; 40(10):883-92. PubMed ID: 18850054 [TBL] [Abstract][Full Text] [Related]
47. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension. Malczyk M; Veith C; Fuchs B; Hofmann K; Storch U; Schermuly RT; Witzenrath M; Ahlbrecht K; Fecher-Trost C; Flockerzi V; Ghofrani HA; Grimminger F; Seeger W; Gudermann T; Dietrich A; Weissmann N Am J Respir Crit Care Med; 2013 Dec; 188(12):1451-9. PubMed ID: 24251695 [TBL] [Abstract][Full Text] [Related]
48. Pulmonary vascular collagen content, not cross-linking, contributes to right ventricular pulsatile afterload and overload in early pulmonary hypertension. Wang Z; Schreier DA; Abid H; Hacker TA; Chesler NC J Appl Physiol (1985); 2017 Feb; 122(2):253-263. PubMed ID: 27856711 [TBL] [Abstract][Full Text] [Related]
49. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. Chassagne C; Eddahibi S; Adamy C; Rideau D; Marotte F; Dubois-Randé JL; Adnot S; Samuel JL; Teiger E Am J Respir Cell Mol Biol; 2000 Mar; 22(3):323-32. PubMed ID: 10696069 [TBL] [Abstract][Full Text] [Related]
50. Impairment of hypoxic pulmonary artery remodeling by heparin in mice. Hales CA; Kradin RL; Brandstetter RD; Zhu YJ Am Rev Respir Dis; 1983 Oct; 128(4):747-51. PubMed ID: 6226226 [TBL] [Abstract][Full Text] [Related]
51. Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma. Berg JT; Breen EC; Fu Z; Mathieu-Costello O; West JB Am J Respir Crit Care Med; 1998 Dec; 158(6):1920-8. PubMed ID: 9847287 [TBL] [Abstract][Full Text] [Related]
52. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling. Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492 [TBL] [Abstract][Full Text] [Related]
53. Temporal alterations in basement membrane components in the pulmonary vasculature of the chronically hypoxic rat: impact of hypoxia and recovery. Vyas-Somani AC; Aziz SM; Arcot SA; Gillespie MN; Olson JW; Lipke DW Am J Med Sci; 1996 Aug; 312(2):54-67. PubMed ID: 8701968 [TBL] [Abstract][Full Text] [Related]
54. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Frid MG; Brunetti JA; Burke DL; Carpenter TC; Davie NJ; Reeves JT; Roedersheimer MT; van Rooijen N; Stenmark KR Am J Pathol; 2006 Feb; 168(2):659-69. PubMed ID: 16436679 [TBL] [Abstract][Full Text] [Related]
55. Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension. Seki M; Furukawa N; Koitabashi N; Obokata M; Conway SJ; Arakawa H; Kurabayashi M PLoS One; 2019; 14(8):e0220795. PubMed ID: 31437169 [TBL] [Abstract][Full Text] [Related]
56. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension. Biasin V; Marsh LM; Egemnazarov B; Wilhelm J; Ghanim B; Klepetko W; Wygrecka M; Olschewski H; Eferl R; Olschewski A; Kwapiszewska G J Pathol; 2014 May; 233(1):7-17. PubMed ID: 24258247 [TBL] [Abstract][Full Text] [Related]
57. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway. Zhang N; Dong M; Luo Y; Zhao F; Li Y Eur J Pharmacol; 2018 Feb; 820():1-7. PubMed ID: 29221952 [TBL] [Abstract][Full Text] [Related]
58. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Li QF; Dai AG Chin Med J (Engl); 2004 Jul; 117(7):1023-8. PubMed ID: 15265376 [TBL] [Abstract][Full Text] [Related]
59. Twist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-β-Smad Signaling. Mammoto T; Muyleart M; Konduri GG; Mammoto A Am J Respir Cell Mol Biol; 2018 Feb; 58(2):194-207. PubMed ID: 28915063 [TBL] [Abstract][Full Text] [Related]
60. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]